Works matching DE "VACCINIA"
Results: 1375
VACCINIA.
- Published in:
- 1941
- Publication type:
- Bibliography
Production of Recombinant Protein Using the HeLa S3-Vaccinia Virus Expression System: Bioreactor Perfusion and Effects of Post-Infection Temperature.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2005, v. 69, n. 6, p. 1065, doi. 10.1271/bbb.69.1065
- By:
- Publication type:
- Article
Recombinant Strains of Oncolytic Vaccinia Virus for Cancer Immunotherapy.
- Published in:
- Biochemistry (00062979), 2023, v. 88, n. 6, p. 823, doi. 10.1134/S000629792306010X
- By:
- Publication type:
- Article
Household Transmission of Vaccinia Virus from Contact with a Military Smallpox Vaccinee -- Illinois and Indiana, 2007.
- Published in:
- 2007
- Publication type:
- Case Study
Vulvar Vaccinia Infection After Sexual Contact with a Military Smallpox Vaccinee -- Alaska, 2006.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2007, v. 56, n. 17, p. 417
- Publication type:
- Article
Secondary and Tertiary Transfer of Vaccinia Virus Among U.S. Military Personnel --United States and Worldwide, 2002-2004.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2004, v. 53, n. 5, p. 103
- By:
- Publication type:
- Article
Women with Smallpox Vaccine Exposure During Pregnancy Reported to the National Smallpox Vaccine in Pregnancy Registry--United States, 2003.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2003, v. 52, n. 17, p. 386
- By:
- Publication type:
- Article
AIMing 2 defend against intracellular pathogens.
- Published in:
- Nature Immunology, 2010, v. 11, n. 5, p. 367, doi. 10.1038/ni0510-367
- By:
- Publication type:
- Article
H5亚型不同分支禽流感病毒HA基因混编文库的构建.
- Published in:
- Chinese Journal of Preventive Veterinary Medicine / Zhongguo Yufang Shouyi Xuebao, 2021, v. 43, n. 12, p. 1245, doi. 10.3969/j.issn.1008-0589.202102016
- By:
- Publication type:
- Article
The formin FHOD1 and the small GTPase Rac1 promote vaccinia virus actin-based motility.
- Published in:
- Journal of Cell Biology, 2013, v. 202, n. 7, p. 1075, doi. 10.1083/jcb.201303055
- By:
- Publication type:
- Article
Flightless-I regulates proinflammatory caspases by selectively modulating intracellular localization and caspase activity.
- Published in:
- Journal of Cell Biology, 2008, v. 181, n. 2, p. 321, doi. 10.1083/jcb.200711082
- By:
- Publication type:
- Article
Single Dose of Attenuated Vaccinia Viruses Expressing H5 Hemagglutinin Affords Rapid and Long-Term Protection Against Lethal Infection with Highly Pathogenic Avian Influenza A H5N1 Virus in Mice and Monkeys.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 74, doi. 10.3390/vaccines13010074
- By:
- Publication type:
- Article
Reactogenicity and Immunogenicity Against MPXV of the Intradermal Administration of Modified Vaccinia Ankara Compared to the Standard Subcutaneous Route.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 32, doi. 10.3390/vaccines13010032
- By:
- Publication type:
- Article
Multi-Component Protein Vaccine Induces a Strong and Long-Term Immune Response Against Monkeypox Virus.
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1410, doi. 10.3390/vaccines12121410
- By:
- Publication type:
- Article
Expression of an Efficient Selection Marker Out of a Duplicated Site in the ITRs of a Modified Vaccinia Virus Ankara (MVA).
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1377, doi. 10.3390/vaccines12121377
- By:
- Publication type:
- Article
Rapid Development of Modified Vaccinia Virus Ankara (MVA)-Based Vaccine Candidates Against Marburg Virus Suitable for Clinical Use in Humans.
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1316, doi. 10.3390/vaccines12121316
- By:
- Publication type:
- Article
A Head-to-Head Comparative Study of the Replication-Competent Vaccinia Virus and AAV1-Based Malaria Vaccine versus RTS,S/AS01 in Murine Models.
- Published in:
- Vaccines, 2024, v. 12, n. 10, p. 1155, doi. 10.3390/vaccines12101155
- By:
- Publication type:
- Article
Vaccination for Mpox (Monkeypox) Infection in Humans: From Basic Science to Real-World Effectiveness.
- Published in:
- Vaccines, 2024, v. 12, n. 10, p. 1147, doi. 10.3390/vaccines12101147
- By:
- Publication type:
- Article
Enhanced Expression of the L1R Gene of Vaccinia Virus by the tPA Signal Sequence Inserted in a Fowlpox-Based Recombinant Vaccine.
- Published in:
- Vaccines, 2024, v. 12, n. 10, p. 1115, doi. 10.3390/vaccines12101115
- By:
- Publication type:
- Article
Development of Smallpox Antibody Testing and Surveillance Following Smallpox Vaccination in the Republic of Korea.
- Published in:
- Vaccines, 2024, v. 12, n. 10, p. 1105, doi. 10.3390/vaccines12101105
- By:
- Publication type:
- Article
Dose Considerations for Vaccinia Oncolytic Virus Based on Retrospective Reanalysis of Early and Late Clinical Trials.
- Published in:
- Vaccines, 2024, v. 12, n. 9, p. 1010, doi. 10.3390/vaccines12091010
- By:
- Publication type:
- Article
Characterization of the Monkeypox Virus [MPX]-Specific Immune Response in MPX-Cured Individuals Using Whole Blood to Monitor Memory Response.
- Published in:
- Vaccines, 2024, v. 12, n. 9, p. 964, doi. 10.3390/vaccines12090964
- By:
- Publication type:
- Article
Viral Vector-Based Chlamydia trachomatis Vaccines Encoding CTH522 Induce Distinct Immune Responses in C57BL/6J and HLA Transgenic Mice.
- Published in:
- Vaccines, 2024, v. 12, n. 8, p. 944, doi. 10.3390/vaccines12080944
- By:
- Publication type:
- Article
A Pseudovirus Nanoparticle Displaying the Vaccinia Virus L1 Protein Elicited High Neutralizing Antibody Titers and Provided Complete Protection to Mice against Mortality Caused by a Vaccinia Virus Challenge.
- Published in:
- Vaccines, 2024, v. 12, n. 8, p. 846, doi. 10.3390/vaccines12080846
- By:
- Publication type:
- Article
Enhanced Immune Responses in Mice by Combining the Mpox Virus B6R-Protein and Aluminum Hydroxide-CpG Vaccine Adjuvants.
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 776, doi. 10.3390/vaccines12070776
- By:
- Publication type:
- Article
Immunity to Tick-Borne Encephalitis Virus NS3 Protein Induced with a Recombinant Modified Vaccinia Virus Ankara Fails to Afford Mice Protection against TBEV Infection.
- Published in:
- Vaccines, 2024, v. 12, n. 1, p. 105, doi. 10.3390/vaccines12010105
- By:
- Publication type:
- Article
Protective MVA-ST Vaccination Robustly Activates T Cells and Antibodies in an Aged-Hamster Model for COVID-19.
- Published in:
- Vaccines, 2024, v. 12, n. 1, p. 52, doi. 10.3390/vaccines12010052
- By:
- Publication type:
- Article
Vaccination with an HIV T-Cell Immunogen (HTI) Using DNA Primes Followed by a ChAdOx1-MVA Boost Is Immunogenic in Gut Microbiota-Depleted Mice despite Low IL-22 Serum Levels.
- Published in:
- Vaccines, 2023, v. 11, n. 11, p. 1663, doi. 10.3390/vaccines11111663
- By:
- Publication type:
- Article
Evaluation of Cross-Immunity to the Mpox Virus Due to Historic Smallpox Vaccination.
- Published in:
- Vaccines, 2023, v. 11, n. 10, p. 1541, doi. 10.3390/vaccines11101541
- By:
- Publication type:
- Article
A Subunit Vaccine Candidate Composed of Mpox Virus A29L, M1R, A35R, and B6R Elicits Robust Immune Response in Mice.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1420, doi. 10.3390/vaccines11091420
- By:
- Publication type:
- Article
Immunogenicity and Safety of Modified Vaccinia Ankara (MVA) Vaccine—A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1410, doi. 10.3390/vaccines11091410
- By:
- Publication type:
- Article
A Monoclonal Antibody Produced in Glycoengineered Plants Potently Neutralizes Monkeypox Virus.
- Published in:
- Vaccines, 2023, v. 11, n. 7, p. 1179, doi. 10.3390/vaccines11071179
- By:
- Publication type:
- Article
The Global Monkeypox (Mpox) Outbreak: A Comprehensive Review.
- Published in:
- Vaccines, 2023, v. 11, n. 6, p. 1093, doi. 10.3390/vaccines11061093
- By:
- Publication type:
- Article
Vaccinia Virus Strain MVA Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 1006, doi. 10.3390/vaccines11051006
- By:
- Publication type:
- Article
Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice.
- Published in:
- Vaccines, 2023, v. 11, n. 4, p. 714, doi. 10.3390/vaccines11040714
- By:
- Publication type:
- Article
Successful Outcome after Treatment with Cidofovir, Vaccinia, and Extended Course of Tecovirimat in a Newly-Diagnosed HIV Patient with Severe Mpox: A Case Report.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 650, doi. 10.3390/vaccines11030650
- By:
- Publication type:
- Article
Needle-Free Devices and CpG-Adjuvanted DNA Improve Anti-HIV Antibody Responses of Both DNA and Modified Vaccinia Ankara-Vectored Candidate Vaccines.
- Published in:
- Vaccines, 2023, v. 11, n. 2, p. 376, doi. 10.3390/vaccines11020376
- By:
- Publication type:
- Article
Evaluation of the Effect of CD70 Co-Expression on CD8 T Cell Response in Protein-Prime MVA-Boost Vaccination in Mice.
- Published in:
- Vaccines, 2023, v. 11, n. 2, p. 245, doi. 10.3390/vaccines11020245
- By:
- Publication type:
- Article
Biothermodynamics of Viruses from Absolute Zero (1950) to Virothermodynamics (2022).
- Published in:
- Vaccines, 2022, v. 10, n. 12, p. 2112, doi. 10.3390/vaccines10122112
- By:
- Publication type:
- Article
Disease History, Pathogenesis, Diagnostics, and Therapeutics for Human Monkeypox Disease: A Comprehensive Review.
- Published in:
- Vaccines, 2022, v. 10, n. 12, p. 2091, doi. 10.3390/vaccines10122091
- By:
- Publication type:
- Article
Design Strategies and Precautions for Using Vaccinia Virus in Tumor Virotherapy.
- Published in:
- Vaccines, 2022, v. 10, n. 9, p. 1552, doi. 10.3390/vaccines10091552
- By:
- Publication type:
- Article
Development of Modified Vaccinia Virus Ankara-Based Vaccines: Advantages and Applications.
- Published in:
- Vaccines, 2022, v. 10, n. 9, p. 1516, doi. 10.3390/vaccines10091516
- By:
- Publication type:
- Article
Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and Camels.
- Published in:
- Vaccines, 2022, v. 10, n. 8, p. 1330, doi. 10.3390/vaccines10081330
- By:
- Publication type:
- Article
Intranasal Immunization with a Vaccinia Virus Vaccine Vector Expressing Pre-Fusion Stabilized SARS-CoV-2 Spike Fully Protected Mice against Lethal Challenge with the Heavily Mutated Mouse-Adapted SARS2-N501Y MA30 Strain of SARS-CoV-2.
- Published in:
- Vaccines, 2022, v. 10, n. 8, p. 1172, doi. 10.3390/vaccines10081172
- By:
- Publication type:
- Article
Protective Human Anti-Poxvirus Monoclonal Antibodies Are Generated from Rare Memory B Cells Isolated by Multicolor Antigen Tetramers.
- Published in:
- Vaccines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/vaccines10071084
- By:
- Publication type:
- Article
Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein.
- Published in:
- Vaccines, 2022, v. 10, n. 4, p. N.PAG, doi. 10.3390/vaccines10040533
- By:
- Publication type:
- Article
Oncolytic Vaccinia Virus in Lung Cancer Vaccines.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 240, doi. 10.3390/vaccines10020240
- By:
- Publication type:
- Article
Orally Administrated Recombinant Vaccinia Virus Displaying ROP4 Induces Protection against Toxoplasma gondii Challenge Infection.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 152, doi. 10.3390/vaccines10020152
- By:
- Publication type:
- Article
Characterization of an In Vivo Neutralizing Anti-Vaccinia Virus D8 Single-Chain Fragment Variable (scFv) from a Human Anti-Vaccinia Virus-Specific Recombinant Library.
- Published in:
- Vaccines, 2021, v. 9, n. 11, p. 1308, doi. 10.3390/vaccines9111308
- By:
- Publication type:
- Article
Advancements in the Growth and Construction of Recombinant Lumpy Skin Disease Virus (LSDV) for Use as a Vaccine Vector.
- Published in:
- Vaccines, 2021, v. 9, n. 10, p. 1131, doi. 10.3390/vaccines9101131
- By:
- Publication type:
- Article